Designs and chemically synthesizes natural product–like screening libraries (fragments, covalent binders, HTS & DEL) with in‑house hit‑to‑lead optimization. Delivers custom synthesis, medicinal chemistry, AS‑MS screening and protein/RNA target qualification to accelerate lead discovery for pharma and biotech research organizations.